Sort
10,829 grants matching “car t”
Impact of the intestinal microbiota on CAR T cell therapy response
$47,694Pamela Herrera · Weill Medical Coll Of Cornell Univ · F31 · FY2023 · CA
Focused ultrasound control of intratumoral NKG2DL BTE production by CART cells to potentiate epitope spread
$47,694Ali Zamat · Georgia Institute Of Technology · F31 · FY2023 · CA
MECHANISM OF RETINAL DAMAGE IN AUTOIMMUNE RETINOPATHY
$47,603Brett G Jeffrey · Oregon Health & Science University · P51 · FY2010 · RR
Immuno-Oncology
$47,591Jose R Conejo-Garcia · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2025 · CA
Antibody discovery
$47,590Anton Simeonov · National Center For Advancing Translational Sciences · ZIA · FY2019 · TR
Identification of small molecule enhancers of CAR-T cell killing activity
$47,590Matthew Hall · National Center For Advancing Translational Sciences · ZIA · FY2019 · TR
Immuno-Oncology
$47,589Jose R Conejo-Garcia · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2024 · CA
Immuno-Oncology
$47,588Jose R Conejo-Garcia · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2023 · CA
ROLE OF ADENOVIRAL RECEPTORS IN GENE THERAPY OF DIABETES
$47,348Ohio State University · F32 · FY2001 · DK
Latin America Treatment & Innovation Network in Mental Health (LANTIN-MH)
$47,270Paulo Rossi Menezes · Fundacao Faculdade De Medicina · U19 · FY2015 · MH
Immunology Research Program
$47,171Gianpietro Dotti · Univ Of North Carolina Chapel Hill · P30 · FY2025 · CA
Improving the Efficacy of Allogeneic Cell Therapies of Cancer
$47,020Feiyan Mo · Baylor College Of Medicine · F99 · FY2020 · CA
Development of senolytic CAR T cells as new therapeutic agents
$47,020Corina Amor Vegas · Sloan-Kettering Inst Can Research · F99 · FY2020 · CA
Enhancing Treg Therapeutic Efficacy in GVHD with CARs
$47,016Sara Bolivar Wagers · University Of Minnesota · F30 · FY2022 · HL
IGF::OT::IGF INFINITY CONFERENCE GROUP INC: 1108883
$46,976Doreen Albertson · · N02 · FY2017 · DA
Immunology and Cancer
$46,927Thomas F Gajewski · University Of Chicago · P30 · FY2024 · CA
EpoxySEAKER and onSEAKER: CAR T-Cell Systems for Targeted Local Biosynthesis of Therapeutic Warheads
$46,752Broderick C Corless · Weill Medical Coll Of Cornell Univ · F31 · FY2022 · CA
Mechanisms of TET2-dependent control of CAR T cell fate determination and antitumor function
$46,752Caitlin Rosemary Hopkins · University Of Pennsylvania · F31 · FY2022 · CA
Novel non-genotoxic ligand-based CD117-directed CAR T conditioning in the context of hematopoietic stem cell transplantation and leukemia treatment
$46,752Gianna Branella · Emory University · F31 · FY2022 · CA
Focused ultrasound control of intratumoral NKG2DL BTE production by CART cells to potentiate epitope spread
$46,752Ali Zamat · Georgia Institute Of Technology · F31 · FY2022 · CA
Defining Antigen-Dependent and Antigen-Independent Mechanisms for EGFRviii-Expressing Tumor Escape From Therapy
$46,752Jack H Swanson · Mayo Clinic Rochester · F31 · FY2022 · CA
Boston Speech Motor Control Symposium
$46,741Jennifer Michele Vojtech · Boston University (Charles River Campus) · R13 · FY2025 · DC
Genome Engineered Natural Killer Cell Immunotherapy against Human Osteosarcoma
$46,683Gabrielle Matilde Robbins · University Of Minnesota · F30 · FY2024 · OD
Engineering High-Affinity T Cell Receptors Against Cancer Antigens
$46,613Daniel Harris · University Of Illinois At Urbana-Champaign · F30 · FY2015 · CA
STEREOTYPIES IN CHILDREN WITH DEVELOPMENTAL DISORDERS
$46,587University Of Washington · R03 · FY2001 · MH